0001140361-18-009548.txt : 20180222
0001140361-18-009548.hdr.sgml : 20180222
20180222131057
ACCESSION NUMBER: 0001140361-18-009548
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180216
FILED AS OF DATE: 20180222
DATE AS OF CHANGE: 20180222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VandenEnden Koert
CENTRAL INDEX KEY: 0001732118
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 18631913
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA CORP.
STREET 2: SUITE 100, 8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
3
1
doc1.xml
FORM 3
X0206
3
2018-02-16
0
0001447028
Arbutus Biopharma Corp
ABUS
0001732118
VandenEnden Koert
C/O ARBUTUS BIOPHARMA CORPORATION
SUITE 100, 8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
0
1
0
0
Interim CFO
Common Shares
2750
D
Stock Options (Right to Buy)
3.05
2016-12-07
2026-10-03
Common Shares
35000
D
Stock Options (Right to Buy)
3.15
2017-03-24
2027-03-24
Common Shares
15000
D
Grant date is reflected above. The options vest as follows: 1/3 on 10/3/2017; 1/3 on 10/3/2018 and 1/3 on 10/3/2019.
Grant date is reflected above. The options vest as follows: 1/3 on 3/24/2018; 1/3 on 3/24/2019; and 1/3 on 3/24/2020.
/s/ Koert VandenEnden
2018-02-20